SCYNEXIS

SCYNEXIS Buyback Yield

Buyback Yield of SCYNEXIS (SCYX) as of Sep 28, 2026.

Buyback Yield

0.00

Last updated:

Buyback Yield of SCYNEXIS is 2026 0.00 . Buyback Yield of SCYNEXIS was 2025 0.00 . It decreases by % lower compared to the previous year.

The SCYNEXIS Buyback Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Buyback Yield
Date
Buyback Yield
Jan 1, 2018
100.71 USD
Jan 1, 2019
147.38 USD
Jan 1, 2020
0.66 USD
Jan 1, 2021
122.56 USD
Jan 1, 2022
0.00 USD
Jan 1, 2023
0.00 USD
Jan 1, 2024
0.00 USD
Jan 1, 2025
0.00 USD
The SCYNEXIS Buyback Yield history
YEARBuyback YieldYoY
0.00—
0.00—
0.00—
0.00-100.00%
122.56 %+18,445.19%
0.66 %-99.55%
147.38 %+46.35%
100.71 %+207.07%
32.80 %-63.26%
89.27 %-32.31%
131.87 %-33.78%
199.14 %—
Access this data via the Eulerpool API

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCYNEXIS stock

On Eulerpool you can find the complete historical development of Buyback Yield SCYNEXIS since 2006 – with annual values, charts, and detailed analysis.

Buyback yield measures the percentage of market cap returned to shareholders through share repurchases. It complements dividend yield in assessing total shareholder returns.

To evaluate Buyback Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Buyback Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Buyback Yield's SCYNEXIS with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — SCYNEXIS

All Key Metrics — SCYNEXIS